Chubb Limited currently trades at a 4.2% premium to its mean analyst target, positioning the stock as a notable outlier compared to the 9.5% average upside seen across the broader Financials sector.
Price vs targets
As of July 4, 2026, the market has priced Chubb at $361.17, while the consensus among 23 analysts settles at $346.09. This discrepancy is particularly interesting given the company's valuation metrics; it currently carries a forward P/E of 12.35, suggesting that professional forecasters are tempering their enthusiasm despite a robust 12.77 trailing P/E. Institutional sentiment remains mixed, as evidenced by ten meaningful insider sell transactions totaling 87,261 shares in recent periods.
| Metric | Value |
|---|---|
| Current Price | $361.17 |
| Mean Target | $346.09 |
| Analysts Tracking | 23 |
| Forward P/E | 12.35 |
Recent activity from research firms shows a lack of consensus on the direction of the target price. Barclays recently moved to lower their target from $375 to $368 on June 12, whereas Piper Sandler pushed their estimate upward to $340 in late May. Keefe, Bruyette & Woods also signaled a slight increase in April, bringing their target to $374. These adjustments underscore the difficulty analysts face when balancing insurance underwriting cycles against current market volatility.
Sector placement
Ranking 22nd within the Financials cohort, Chubb’s negative implied upside stands in stark contrast to high-flying peers. For instance, Intercontinental Exchange (ICE) boasts an implied upside of 45.2%, reflecting a vastly different market expectation for exchange-based operators compared to traditional property and casualty insurers. The spread between Chubb’s current valuation and the consensus target suggests that for now, the street is waiting for the next catalyst—perhaps the earnings print slated for July 21—to recalibrate their models. With a beta of 0.406, the stock has historically demonstrated lower sensitivity to broader market swings, which may explain why analysts are comfortable maintaining a buy recommendation even while the current price sits above their collective mean target.